BioSpace News Archive

ArTara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company identifying and advancing transformative therapies for people with rare and specialty diseases, today announced that it has changed its name to Protara Therapeutics, Inc ., effective immediately. As part of the name change, the Company has launched a new corporate website, www.protaratx.com . The Company’s shares will continue trading on the Nasdaq Capital Market under the ticker sym

Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (the “Company or Cannabix”) developer of marijuana breathalyzer devices for law enforcement and the workplace, is pleased to report that the Company has developed a new version of its THC Breath Analyzer (“THCBA”) and is preparing for additional testing with the device.

Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its subsidiary Kannaway® has launched the first-ever cannabidiol (CBD) fitness program, Evolve.

May 11, 2020 13:00 UTC New Vice President of Medical Affairs Brings 20+ Years of Experience to Growing Leadership Team CAMBRIDGE, Mass.--( BUSINESS WIRE )-- Amylyx Pharmaceuticals, Inc., a pharmaceutical company focused on developing new treatments for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases, today announced the appointment of Machelle Manuel, Ph.D., as Vice President, Head of Global Medical Affairs. Dr. Manuel brings more than 20 years of e

May 11, 2020 13:00 UTC Company appoints new CEO, CFO, General Manager and board member, opens San Diego office SAN DIEGO & REHOVOT, Israel--( BUSINESS WIRE )-- Nucleix , a liquid biopsy company revolutionizing cancer treatment by detecting the disease earlier, today announced the expansion of its operations into the United States and the appointment of new executive and board leadership to support future growth. The company appointed Chris Hibberd as chief executi

ZOLL® Medical Corporation, an Asahi Kasei Group company that manufactures medical devices and related software solutions, announced the return of funds it received from the Department of Health and Human Services (HHS) as part of the CARES Act Provider Relief Fund. The CARES Act Provider Relief Fund allocated $50 billion for distribution to Medicare facilities and providers impacted by COVID-19. HHS provided automa

BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: PVOTF / FRA: NPAT) today announced that it has appointed Dr. Mark Swaim to the board of directors of its wholly-owned subsidiary, Blife Therapeutics Inc.

Seevix Material Sciences Ltd., which develops and manufactures synthetic SVX™ spidersilk, announced today that it plans to use its patented spidersilk technology to create disposable and safe filters with high entrapment and inactivation efficacy to neutralize COVID-19 and other coronaviruses.

Today, Argentum, the leading national association serving senior living providers, has called for transparency in COVID-19 reporting among the states by releasing the following statement and call to action: ____________________ Openness and transparency are critical to maintaining the valued trust of senior living residents, fam

A new research study published in Current Developments in Nutrition found that the equivalent of one cup of fresh blueberries, given as 22 g of freeze-dried blueberries, may beneficially affect areas of health in overweight men with type 2 diabetes.